Wednesday, September 28, 2016

Kiehl's has a New Cause, Ovarian Cancer Research Fund Alliance.

By Laura Medina


Kiehl's has step up and raised awareness and funds for environmentalism and AIDS.  Now, they have taken on a new cause, Ovarian Cancer with OCRFA President & CEO Audra Moran, again to educate the public and find a cure.

Kiehl's knights in shining armor are their motorcycle gang, the LifeRiders.  The core knights/members are: Chris Salgardo, Kiehl’s USA President, Gilles Marini, Grant Reynolds, TV host, and Scott Patterson, Actor.

This was the briefest charity tour that the Kiehl's LifeRiders ever had:  Kiehl’s Sherman Oaks, Westfield Fashion Square, 14006 Riverside Dr., Sherman Oaks, CA 91423, 11:00AM-12:00PM
• Kiehl’s Santa Anita, Westfield Santa Anita, 400 Baldwin Ave., Arcadia, CA 91007, 2:00PM-3:00PM
• Kiehl’s Victoria Gardens, ...Victoria Gardens, 12505 N Main St. #200, Rancho Cucamonga, CA 91739, 4:30PM-5:30PM

Three stops in one day, all in the Inland Empire, on a Wednesday, September 21st.

The motorcycle tour ended on Thursday, September 22nd at Kiehl's Santa Monica store on Montana Avenue boutique.


Kiehl's Midnight Recovery Collection was set aside for proceeds for Ovarian Cancer Research Fund Alliance.


Life long LifeRider, Gilles Marini showed his heart and soul for riding for worthy causes, such as the environment and cancers.


Alyssa Milano, from "Who's the Boss," shows her support for Ovarian Cancer.


America's Ninja Warrior, Jessie Graff demonstrates her prowess.

 
Then, she does pull-ups at the store entrance.


It ain't a Kiehl's party until they present a check for their favorite causes, a $25,000 check donated to the research and education of Ovarian Cancer to Ovarian Cancer Research Fund Alliance.

OCRFA President & CEO Audra Moran wasn't afraid to tell the guests that you can't discover ovarian cancer through the traditional pap smear.  There needs to be more money for more research to properly discover and detect ovarian cancer quicker, easier, and faster then, there's the cure.













No comments: